These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2165559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components.
    Matsukuma A, Enjoji M, Toyoshima S.
    Pathol Res Pract; 1991 Jan; 187(1):62-7. PubMed ID: 1851298
    [Abstract] [Full Text] [Related]

  • 3. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
    He X, Dong DD, Yie SM, Yang H, Cao M, Ye SR, Li K, Liu J, Chen J.
    Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
    [Abstract] [Full Text] [Related]

  • 4. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
    Tupitsyn NN, Kadagidze ZG, Blokhina NG, Baryshnikov AIu, Ermilova VD, Artamonova EV, Moldenhauer G, Bernard A.
    Eksp Onkol; 1990 May; 12(2):54-8. PubMed ID: 1690634
    [Abstract] [Full Text] [Related]

  • 5. Expression of normal and tumor-associated antigens in human breast carcinoma.
    Sawtell NM, DiPersio L, Michael JG, Pesce AJ, Weiss MA.
    Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P.
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK, DesMarais CL.
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [Abstract] [Full Text] [Related]

  • 10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ.
    Anticancer Res; 1999 Aug; 19(3A):2133-9. PubMed ID: 10470161
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
    Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, Cao FL, Zhang JG, Yan WH.
    Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
    [Abstract] [Full Text] [Related]

  • 13. [Expression of a plant associated human cancer antigen in breast cancer].
    Fu J, Tian HM, Qu P, Li M, Zheng XW, Zheng ZH, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):403-5. PubMed ID: 15355643
    [Abstract] [Full Text] [Related]

  • 14. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [Abstract] [Full Text] [Related]

  • 15. Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.
    Schoorl R, Riviere AB, Borne AE, Feltkamp-Vroom TM.
    Am J Pathol; 1976 Sep 01; 84(3):529-44. PubMed ID: 183507
    [Abstract] [Full Text] [Related]

  • 16. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM, Piato S, Silva MA.
    Breast Cancer Res Treat; 2006 Feb 01; 95(3):235-41. PubMed ID: 16322898
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of carcinoembryonic antigen in infiltrating duct carcinomas of the breast: correlation with morphofunctional parameters and prognostic significance.
    d'Amore ES, Gloghini A, Margallo E, Margiocco M, Nicoló G.
    Arch Anat Cytol Pathol; 1986 Feb 01; 34(2):89-94. PubMed ID: 3022656
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
    Möller P, Mattfeldt T, Gross C, Schlosshauer P, Koch A, Koretz K, Moldenhauer G, Kaufmann M, Otto HF.
    Am J Pathol; 1989 Jul 01; 135(1):73-83. PubMed ID: 2549795
    [Abstract] [Full Text] [Related]

  • 20. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Xie F, Wang Q, Chen Y, Gu Y, Mao H, Zeng W, Zhang X.
    Pathol Res Pract; 2010 Nov 15; 206(11):735-9. PubMed ID: 20634005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.